Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
SVA [NASD]
Sinovac Biotech Ltd.
Index- P/E- EPS (ttm)-0.12 Insider Own24.35% Shs Outstand55.02M Perf Week0.25%
Market Cap222.84M Forward P/E- EPS next Y-0.11 Insider Trans- Shs Float45.42M Perf Month25.39%
Income-6.80M PEG- EPS next Q-0.04 Inst Own48.80% Short Float1.37% Perf Quarter7.71%
Sales50.80M P/S4.39 EPS this Y87.50% Inst Trans6.57% Short Ratio1.70 Perf Half Y65.98%
Book/sh2.22 P/B1.82 EPS next Y38.90% ROA-3.20% Target Price3.70 Perf Year99.51%
Cash/sh1.49 P/C2.72 EPS next 5Y12.00% ROE-5.40% 52W Range1.98 - 5.09 Perf YTD28.98%
Dividend- P/FCF- EPS past 5Y0.00% ROI-0.90% 52W High-20.43% Beta1.76
Dividend %- Quick Ratio2.70 Sales past 5Y29.80% Gross Margin63.80% 52W Low104.55% ATR0.19
Employees652 Current Ratio3.00 Sales Q/Q-7.10% Oper. Margin-16.30% RSI (14)62.69 Volatility3.57% 5.53%
OptionableYes Debt/Eq0.24 EPS Q/Q-50.00% Profit Margin-13.40% Rel Volume0.16 Prev Close3.98
ShortableYes LT Debt/Eq0.20 EarningsMay 28 BMO Payout- Avg Volume365.85K Price4.05
Recom3.00 SMA205.92% SMA509.96% SMA20027.34% Volume60,362 Change1.76%
12-Dec-12Initiated Aegis Capital Hold $2.50
07-Jan-11Reiterated Brean Murray Buy $5.50 → $4.80
04-Jan-11Downgrade WBB Securities Buy → Speculative Buy $7.50 → $7.50
11-Nov-10Upgrade Brean Murray Hold → Buy $5.50
20-Apr-10Initiated WBB Securities Buy $7.50
06-Apr-10Downgrade Brean Murray Buy → Hold
13-Feb-09Upgrade SMH Capital Neutral → Accumulate $31 → $27
09-Jul-08Initiated Brean Murray Buy $5
02-Jun-13 02:55AM  China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy at Seeking Alpha
31-May-13 04:05PM  InPlay: Sinovac appoints Nan Wang as CFO Briefing.com
04:05PM  Sinovac Appoints New Chief Financial Officer PR Newswire
30-May-13 05:29AM  InPlay: Sinovac Biotech files New Drug Application for EV71 vaccine and receives filing acceptance from Beijing Drug Administration Briefing.com
05:00AM  Sinovac Files New Drug Application for EV71 Vaccine and Receives Filing Acceptance from Beijing Drug Administration PR Newswire
28-May-13 06:30PM  Deadly Strain of Hand, Foot and Mouth Disease Blocked in Study at Bloomberg +20.54%
04:20PM  Sinovac climbs on 1Q hepatitis A vaccine sales AP
02:41PM  Sinovac Biotech's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
07:10AM  Sinovac Reports Unaudited First Quarter 2013 Financial Results PR Newswire
07:07AM  Q1 2013 SINOVAC BIOTECH LTD Earnings Release - Before Market Open CCBN
26-May-13 04:04AM  Sinovac Biotech Earnings: What Investors Should Watch at Wall St. Cheat Sheet
24-May-13 05:00AM  Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines PR Newswire
17-May-13 05:11AM  Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results PR Newswire
15-May-13 06:15AM  Sinovac Biotech appoints Ernst & Young Hua Ming China as external auditor theflyonthewall.com
06:07AM  Sinovac Appoints Ernst & Young Hua Ming Llp China as External Auditor PR Newswire
14-May-13 06:00AM  Sinovac Presents at the UBS Global Healthcare Conference in May 2013 PR Newswire
03-May-13 01:04PM  SINOVAC BIOTECH LTD Financials EDGAR Online Financials
01-May-13 09:09AM  Scientists Infect Chicks in Race to Halt Bird Flu Spread at Bloomberg -5.06%
30-Apr-13 07:06PM  Scientists Infect Chicks in Race to Halt Bird Flu Spread at Bloomberg
07:48AM  Sinovac Files Annual Report on Form 20-F PR Newswire
18-Apr-13 04:14PM  Sinovac posts 4Q loss as expenses rise AP -9.93%
01:45PM  Why Sinovac Is Poised to Keep Pulling Back at Motley Fool
01:00PM  Sinovac Biotech's CEO Discusses F4Q2012 Results - Earnings Call Transcript at Seeking Alpha
08:02AM  Sinovac Reports Unaudited Fourth Quarter and Full Year 2012 Financial Results PR Newswire
07:17AM  Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo PR Newswire
07:07AM  Q4 2012 SINOVAC BIOTECH LTD Earnings Release - Before Market Open CCBN
07:06AM  InPlay: Sinovac Biotech receives commercial approval in Mexico for seasonal flu vaccine Briefing.com
07:05AM  Sinovac Receives Commercial Approval in Mexico for Seasonal Flu Vaccine PR Newswire
17-Apr-13 11:06AM  Bird Flu Fears Mount in China as Herbal Remedies Run Out at Bloomberg
16-Apr-13 07:49PM  The Best Stocks to Buy Yesterday Were Not on the Dow at Motley Fool
05:53PM  Bird Flu Fears Mount in China as Herbal Remedies Run Out at Bloomberg
15-Apr-13 11:15AM  Flu Pandemic Specter Boosts Outlook for Vaccine Firms and 4 Other Hot Stocks at Wall St. Cheat Sheet +6.75%
07:41AM  Symptom-Free Bird Flu Case Suggests Wider H7N9 Spread at Bloomberg
02:03AM  Bird Flu Surge in China Spurs H7N9 Pandemic Vaccine Preparations at Bloomberg
08-Apr-13 02:42AM  Biotechs Ramping Up On China's Avian Flu Outbreak at Seeking Alpha
05-Apr-13 02:32PM  5 Stocks Poised for Breakouts at TheStreet +9.17%
11:21AM  Fridays movers: Network-equipment shares hammered at MarketWatch
04-Apr-13 12:11PM  Bird Flu: Where Inexact Science Meets a Moat of Opportunity at Motley Fool
02-Apr-13 06:05AM  Sinovac Schedules Conference Call and Webcast for Fourth Quarter and Full Year Unaudited Financial Results PR Newswire
17-Mar-13 05:49AM  China Biotech In Review: Simcere Receives $503 Million Privatization Offer at Seeking Alpha
16-Mar-13 12:00PM  This Week in Biotech at Motley Fool
15-Mar-13 11:10PM  Whoa! These 3 Stocks Didn't Deserve Their Gains at Motley Fool
03:24PM  4 Healthcare Stock Stories for Friday Investment Wellness at Wall St. Cheat Sheet
12:11PM  On The Fly: Midday Wrap theflyonthewall.com
08:39AM  Texas Instruments Hurt and 4 Stocks At 52-Week Highs at Wall St. Cheat Sheet
08:20AM  New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry's Growth in 2012 Marketwired
08:20AM  New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry's Growth in 2012 Marketwire
14-Mar-13 07:42PM  Why Chinese Biotech Sinovac Soared at Motley Fool +17.87%
12:16PM  On The Fly: Midday Wrap theflyonthewall.com
11:16AM  Sinovac climbs on late-stage vaccine study AP
09:07AM  On The Fly: Pre-market Movers at theflyonthewall.com
07:38AM  InPlay: Sinovac Biotech reports preliminary top-line results from Phase III clinical trial for EV71 vaccine candidate against hand, foot and mouth disease; results demonstrate vaccine efficacy rate of 95.4% Briefing.com
06:55AM  Sinovac vaccine meets main goal of late-stage study at Reuters
06:37AM  Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease PR Newswire
10-Jan-13 04:41PM  ChartWatch: Two Speculative Flu Stocks Wyatt Investment Research
02:03PM  Four potential breakouts to watch at MarketWatch
28-Dec-12 08:34AM  SJ Strategic Investments reports 5.09% stake in Sinovac Biotech theflyonthewall.com +8.74%
24-Dec-12 03:19AM  5 Biotech Winners From Last Week With High Short Ratios at Seeking Alpha -10.98%
12-Dec-12 01:44PM  Crane Initiated at Buy and 2 Initiated Stocks Making Rounds at Wall St. Cheat Sheet
12:14AM  Coverage initiated on Sinovac Biotech by Aegis Capital Briefing.com
19-Nov-12 04:08AM  Sinovac Biotech Ltd. Stock Downgraded (SVA) at TheStreet
17-Nov-12 09:32AM  New Star Analyst Rankings for Sinovac Biotech, Ltd. StarMine
16-Nov-12 09:27AM  New Star Analyst Rankings for Sinovac Biotech, Ltd. StarMine
09:26AM  Sinovac Biotech's CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
15-Nov-12 10:31AM  Sinovac 3Q loss widens, public vaccine sales fall AP -10.18%
07:07AM  Q3 2012 SINOVAC BIOTECH LTD Earnings Release - Before Market Open CCBN
05:23AM  Sinovac Reports Unaudited Third Quarter 2012 Financial Results PR Newswire
29-Oct-12 08:00AM  Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results PR Newswire
16-Oct-12 05:00AM  Sinovac Biotech Ltd. Stock Upgraded (SVA) at TheStreet
25-Sep-12 02:28PM  4 Biotech Stocks Under $10 Soaring Higher at TheStreet +7.63%
01:01PM  Vail Resorts, Sinovac Biotech: Biggest Price Gainers (MTN, SVA) at The Wall Street Journal
08:10AM  Sinovac Biotech awarded tenders for Hep A vaccine at theflyonthewall.com
08:04AM  InPlay: Sinovac Biotech receives tenders in Beijing and Shanghai to supply inactivated Hepatitis A vaccine healive under expanded immunization program Briefing.com
08:00AM  Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine HealiveĀ® Under Expanded Immunization Program PR Newswire
18-Sep-12 08:01AM  InPlay: Sinovac Biotech receives GMP certification for mumps vaccine production facility; On track to commence commercial production in Q3 2012 Briefing.com +8.44%
08:00AM  Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility PR Newswire
10-Sep-12 08:07AM  InPlay: Sinovac Biotech receives Beijing CDC tender award to supply seasonal flu vaccine Anflu to Beijing Citizens Briefing.com
08:06AM  Sinovac Biotech receives Beijing CDC tender award to supply vaccine at theflyonthewall.com
08:00AM  Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens PR Newswire
09-Sep-12 08:03AM  3 Vaccine Companies With Upcoming Catalysts at Seeking Alpha
23-Aug-12 08:00AM  Sinovac Holds 2012 Annual General Meeting of Shareholders PR Newswire
16-Aug-12 09:40AM  New Star Analyst Rankings for Sinovac Biotech, Ltd. StarMine
15-Aug-12 11:59AM  Sinovac Biotech's CEO Discusses Q2 2012 Results - Earnings Call Transcript at Seeking Alpha
07:07AM  Q2 2012 SINOVAC BIOTECH LTD Earnings Release - Before Market Open CCBN
06:00AM  Sinovac Reports Unaudited Second Quarter 2012 Financial Results PR Newswire
06-Aug-12 08:00AM  Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results PR Newswire
16-Jul-12 08:00AM  Sinovac Schedules 2012 Annual Meeting of Shareholders PR Newswire
25-Jun-12 08:04AM  InPlay: Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status; Phase III clinical trial progressing with successful EV71 case identifications Briefing.com
08:00AM  Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status PR Newswire
18-Jun-12 08:00AM  Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus PR Newswire
11-Jun-12 08:05AM  Sinovac Biotech reports progress in EV71 vaccine Phase III clinical trial theflyonthewall.com
08:02AM  InPlay: Sinovac Biotech announced a positive SFDA inspection of the three clinical trial sites being used in the Company's Phase III study of its proprietary inactivated Enterovirus 71 (EV71) vaccine against hand, foot and mouth disease Briefing.com
08:00AM  Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial PR Newswire
17-May-12 05:00AM  Sinovac Biotech Ltd. Stock Downgraded (SVA) at TheStreet -6.88%
16-May-12 09:42AM  New Star Analyst Rankings for Sinovac Biotech, Ltd. StarMine
15-May-12 07:07AM  Q1 2012 SINOVAC BIOTECH LTD Earnings Release - Before Market Open CCBN -5.91%
06:33AM  Sinovac Reports Unaudited First Quarter 2012 Financial Results PR Newswire
14-May-12 08:05AM  InPlay: Sinovac Biotech names Danny Chung Chief Financial Officer Briefing.com -5.14%
08:00AM  Sinovac Names Danny Chung Chief Financial Officer PR Newswire
08-May-12 08:00AM  Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results PR Newswire
Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. Its products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine; split viron pandemic influenza vaccine; and RabEnd, a animal rabies vaccine. The company has also completed a phase I clinical trial of a SARS vaccine. In addition, it develops the EV71 vaccine, which has completed clinical trials. Further, the company develops a pipeline of vaccine candidates in the clinical and pre-clinical development phases, including human vaccines for pneumococcal, rotavirus, rabies, varicella, and rubella that are in pre-clinical stage. It has a collaboration agreement with Tianjing CanSino Biotechnology Inc. to develop a pneumococcal vaccine; and a license agreement with Medimmune, LLC to use patented reverse genetics technology pertaining to virus strain production for vaccines, including the H5N1 influenza virus strain. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.